We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$20.3B
AUM Growth
+$1.22B
Cap. Flow
-$160M
Cap. Flow %
-0.79%
Top 10 Hldgs %
22.03%
Holding
1,796
New
121
Increased
266
Reduced
599
Closed
60

Top Buys

Rank Stock Value
1
TE
T1 Energy
TE
+$60.5M
2
PFE icon
Pfizer
PFE
+$44M
3
GXO icon
GXO Logistics
GXO
+$37.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$31.2M
5
JD icon
JD.com
JD
+$29.6M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$57.2M
2
BABA icon
Alibaba
BABA
+$57.2M
3
AMRC icon
Ameresco
AMRC
+$55.4M
4
SIVB
SVB Financial Group
SIVB
+$43.1M
5
WOLF icon
Wolfspeed
WOLF
+$41.1M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 17.92%
3 Consumer Discretionary 13.84%
4 Financials 12.09%
5 Industrials 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGC icon
1551
BGC Group
BGC
$5.12B
$357K ﹤0.01%
76,778
– –
INVA icon
1552
Innoviva
INVA
$1.5B
$357K ﹤0.01%
20,676
– –
PBI icon
1553
Pitney Bowes
PBI
$2.28B
$356K ﹤0.01%
53,700
+21,600
+67% +$153K
FIRY
1554
Firy Inc
FIRY
$156M
$356K ﹤0.01%
+2,390
New +$459K
CRSR icon
1555
Corsair Gaming
CRSR
$1.4B
$355K ﹤0.01%
+16,900
New +$404K
EIG icon
1556
Employers Holdings
EIG
$864M
$353K ﹤0.01%
8,537
– –
LILA icon
1557
Liberty Latin America Class A
LILA
$1.69B
$353K ﹤0.01%
+44,602
New +$371K
TPTX
1558
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$353K ﹤0.01%
7,400
-185,400
-96% -$8.29M
BGS icon
1559
B&G Foods
BGS
$291M
$350K ﹤0.01%
11,388
– –
SILK
1560
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$349K ﹤0.01%
8,200
-300
-4% -$15K
CTEV
1561
Claritev Corp
CTEV
$599M
$346K ﹤0.01%
+1,953
New +$348K
HRMY icon
1562
Harmony Biosciences
HRMY
$2.32B
$345K ﹤0.01%
+8,100
New +$323K
SCHL icon
1563
Scholastic
SCHL
$792M
$345K ﹤0.01%
8,623
– –
CLDX icon
1564
Celldex Therapeutics
CLDX
$3.52B
$344K ﹤0.01%
+8,900
New +$388K
CSTL icon
1565
Castle Biosciences
CSTL
$960M
$343K ﹤0.01%
8,000
-200
-2% -$10.5K
PAR icon
1566
PAR Technology
PAR
$741M
$343K ﹤0.01%
6,500
– –
FLGT icon
1567
Fulgent Genetics
FLGT
$515M
$342K ﹤0.01%
3,400
-800
-19% -$70.3K
OSIS icon
1568
OSI Systems
OSIS
$3.82B
$342K ﹤0.01%
3,665
– –
LMND icon
1569
Lemonade
LMND
$4B
$341K ﹤0.01%
8,100
– –
IRWD icon
1570
Ironwood Pharmaceuticals
IRWD
$714M
$338K ﹤0.01%
28,955
– –
AVNS
1571
DELISTED
Avanos Medical
AVNS
$337K ﹤0.01%
9,716
-4,600
-32% -$149K
BANC icon
1572
Banc of California
BANC
$3.1B
$337K ﹤0.01%
17,195
– –
CMPR icon
1573
Cimpress
CMPR
$2.4B
$337K ﹤0.01%
4,700
– –
SBGI icon
1574
Sinclair Inc
SBGI
$1B
$335K ﹤0.01%
12,667
– –
AEVA
1575
Aeva Technologies
AEVA
$1.75B
$334K ﹤0.01%
+8,840
New +$371K
61 62
63
64 65

Similar funds

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Handelsbanken Fonder's Q4 2021 Portfolio in Review

As of Q4 2021, Handelsbanken Fonder held 1,796 positions worth $20.3B, up 6.4% from $19.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Handelsbanken Fonder's Q4 2021 filing shows 121 new, 266 increased, 599 reduced and 60 closed positions. Its largest new stake was T1 Energy: 5,589,851 shares worth $62.5M. The largest sale was NVIDIA, an estimated $57.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Handelsbanken Fonder's largest Q4 2021 buy was T1 Energy: 5,589,851 shares worth $62.5M.
  • Handelsbanken Fonder added most to Pfizer in Q4 2021, an estimated $44M increase.
  • Handelsbanken Fonder's biggest Q4 2021 reduction was NVIDIA, cutting an estimated $57.2M.
  • Handelsbanken Fonder fully exited Acceleron Pharma in Q4 2021, selling an estimated $27.5M.
  • Handelsbanken Fonder's ten largest holdings make up 22% of its $20.3B portfolio in Q4 2021.
  • Handelsbanken Fonder opened 121 new positions and closed 60 in Q4 2021.
  • Handelsbanken Fonder's portfolio value rose 6.4% quarter-over-quarter to $20.3B.

Based on Handelsbanken Fonder's 13F filing for Q4 2021, filed 8 Feb 2022.